Firazyr Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - icatibant - ofsabjúgur, arfgengur - hjarta meðferð - firazyr er ætlað til meðferðar við bráðri árás arfgengs ofsabjúgs (hae) hjá fullorðnum (með skort á c1-esterasa-hemlum).

Apealea Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

apealea

inceptua ab - paklitaxel - Æxli í eggjastokkum - antineoplastic agents, taxanes - apealea ásamt carboplatín er ætlað fyrir meðferð fullorðinn sjúklinga með fyrsta kasti platínu‑viðkvæm þekju eggjastokkum, aðal kviðarholi krabbamein og eggjaleiðara krabbamein.

Vaxchora Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

vaxchora

bavarian nordic a/s - vibrio cholerae, álag cvd 103-hgr, lifandi - cholera - bóluefni - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. Þetta bóluefni ætti að vera notuð í samræmi við opinbera tillögur.

Icatibant Accord Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

icatibant accord

accord healthcare s.l.u. - icatibant acetate - ofsabjúgur, arfgengur - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

Icatibant STADA Stungulyf, lausn í áfylltri sprautu 30 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

icatibant stada stungulyf, lausn í áfylltri sprautu 30 mg

stada arzneimittel ag - icatibantum inn - stungulyf, lausn í áfylltri sprautu - 30 mg